FI952294A0 - Process for the preparation of taxane derivatives, thus obtained new taxanes and containing antitumor and antileukemic compositions - Google Patents

Process for the preparation of taxane derivatives, thus obtained new taxanes and containing antitumor and antileukemic compositions

Info

Publication number
FI952294A0
FI952294A0 FI952294A FI952294A FI952294A0 FI 952294 A0 FI952294 A0 FI 952294A0 FI 952294 A FI952294 A FI 952294A FI 952294 A FI952294 A FI 952294A FI 952294 A0 FI952294 A0 FI 952294A0
Authority
FI
Finland
Prior art keywords
antileukemic
compositions
preparation
obtained new
taxane derivatives
Prior art date
Application number
FI952294A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI952294A (en
Inventor
Jean-Dominique Bourzat
Alain Commercon
Dominique Deprez
Jean-Pierre Pulicani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI952294A0 publication Critical patent/FI952294A0/en
Publication of FI952294A publication Critical patent/FI952294A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042—Electrodes formed of a single material
    • C25B11/046—Alloys
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Metallurgy (AREA)
  • Electrochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
FI952294A 1992-11-12 1995-05-11 Process for the preparation of taxane derivatives, novel taxanes thus obtained and antitumor and anti-leukemic compositions containing them FI952294A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213586A FR2697841B1 (en) 1992-11-12 1992-11-12 New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
PCT/FR1993/001102 WO1994011547A1 (en) 1992-11-12 1993-11-10 Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same

Publications (2)

Publication Number Publication Date
FI952294A0 true FI952294A0 (en) 1995-05-11
FI952294A FI952294A (en) 1995-05-11

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952294A FI952294A (en) 1992-11-12 1995-05-11 Process for the preparation of taxane derivatives, novel taxanes thus obtained and antitumor and anti-leukemic compositions containing them

Country Status (15)

Country Link
EP (1) EP0667922A1 (en)
JP (1) JPH08503261A (en)
KR (1) KR950704540A (en)
AU (1) AU5425794A (en)
CA (1) CA2149240A1 (en)
CZ (1) CZ122495A3 (en)
FI (1) FI952294A (en)
FR (1) FR2697841B1 (en)
MX (1) MX9306883A (en)
NO (1) NO951772L (en)
PL (1) PL308957A1 (en)
RU (1) RU95112464A (en)
SK (1) SK60895A3 (en)
WO (1) WO1994011547A1 (en)
ZA (1) ZA938366B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (en) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the pharmaceutical compositions containing them.
FR2711369B1 (en) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the compositions containing them.
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
KR101535395B1 (en) * 2004-01-22 2015-07-08 유니버시티 오브 마이애미 Topical co-enzyme q10 formulations and methodns of use
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EA201101519A1 (en) 2009-05-11 2012-10-30 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи METHODS OF DIAGNOSTICS OF METABOLIC DISTURBANCES USING EPIMETABOLIC SWITCHES, MULTIPLE-DIFFERENT INTRACELLULAR MOLECULES OR IMPACT FACTORS
JP6092844B2 (en) 2011-04-04 2017-03-08 バーグ エルエルシー Treatment of central nervous system tumors
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
BR112015025424A2 (en) 2013-04-08 2017-07-18 Berg Llc cancer treatment using coenzyme q10 combination therapies
JP6595478B2 (en) 2013-09-04 2019-10-23 バーグ エルエルシー Cancer treatment by continuous injection of coenzyme Q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
AU5425794A (en) 1994-06-08
ZA938366B (en) 1994-06-13
MX9306883A (en) 1995-01-31
SK60895A3 (en) 1996-03-06
WO1994011547A1 (en) 1994-05-26
EP0667922A1 (en) 1995-08-23
KR950704540A (en) 1995-11-20
NO951772D0 (en) 1995-05-05
FR2697841B1 (en) 1995-01-13
JPH08503261A (en) 1996-04-09
RU95112464A (en) 1997-02-20
CZ122495A3 (en) 1995-12-13
CA2149240A1 (en) 1994-05-26
FI952294A (en) 1995-05-11
FR2697841A1 (en) 1994-05-13
PL308957A1 (en) 1995-09-04
NO951772L (en) 1995-05-05

Similar Documents

Publication Publication Date Title
FI952294A0 (en) Process for the preparation of taxane derivatives, thus obtained new taxanes and containing antitumor and antileukemic compositions
FI935821A0 (en) Phosphonooxymethyl esters of taxanes
FI940191A0 (en) New derivatives, which are taxol analogs, preparation of them and these containing compositions
FI941137A0 (en) 2-debenzoyl-2-acyl taxol derivatives and processes for their preparation
NO943002L (en) Phosphonoxymethyl ethers of taxane derivatives
FI931163A (en) COMPOSITION INNEHAOLLANDE KOMBINATIONER AV YTAKTIVA MEDEL OCH BAERNSTENSYRAACYLERINGSMEDELDERIVAT ELLER HYDROXIAROMATISKA AEMNEN OCH ANVAENDNING AV DESSA
FI882945A (en) Process for the preparation of antihypertensive and antiarrhythmic trans-2,2-dimethylchroman-3-parent derivatives
FI970099A0 (en) Fungicidal compositions containing 3-phenylpyrate sol derivatives for the treatment of propagative plant material, novel 3-phenylpyrate sol derivatives and their fungicidal use
FI951789A0 (en) Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
FI943645A0 (en) New backatin-III and 10-deacetylbackatin-III derivatives, preparation of them and these containing pharmaceutical compositions
FI945780A (en) New biologically active eburnamenine derivatives, pharmaceutical compositions containing them and processes for their preparation
FI940775A (en) Process for the preparation and use of alpha-phenylisoserine derivatives
FI903173A0 (en) Process for the preparation of adhesive and coating mixture and the mixture prepared
FI942222A (en) Process for the preparation of dry-treated particles, so obtained dry-treated particles and pharmaceutical compositions containing them
FI945439A (en) Novel taxane derivatives, their preparation and compositions containing them
FI981359A (en) New thiomarinol derivatives and processes for their preparation
FI964900A0 (en) New taxoids, their preparation and those containing pharmaceutical compositions
FI951561A (en) New 17-Substituted 4-Androstane Derivatives, Pharmaceutical Compositions Containing Them, and Process for Preparing the Same
FI942675A (en) New substituted oxazinoisoquinoline derivatives, pharmaceutical compositions containing them and processes for their preparation
SE7903554L (en) NEW ISOKINOLIN DERIVATIVES, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA919224B (en) Process for preparing taxane derivatives,new derivatives obtained and pharmaceutical compositions containing them
ZA934741B (en) New derivatives of 10-deacetylbaccatin III, their preparation and pharmaceutical compositions containing them.
FI96693C (en) Process for the preparation of novel 3 '- (4-morpholinyl) and 3' - (2-methoxy-4-morpholinyl) anthracycline derivatives useful as anti-tumor agents
NO940247D0 (en) Process for the preparation of 13-cinnamoyl baccatin III or 10-deacetyl baccatin III
FI940223A0 (en) New 6-Substituted Steroids, Process for Preparing Them, and Pharmaceutical Compositions Containing These Steroids

Legal Events

Date Code Title Description
FD Application lapsed